Galectin Therapeutics Inc - fluxo de caixa (NASDAQ:GALT) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -20.6 M-24.31 M-31.06 M-32.97 M-41.77 M-23.88 M -23.88 M Cash from investing activities 000000 — Cash from financing activities 263 K36.81 M10 M40.03 M31.23 M26.48 M 26.48 M Free cash flow -20.6 M-24.31 M-31.06 M-32.97 M-41.77 M-23.88 M -23.88 M

Notícias

Galectin Therapeutics nomeia neurocirurgião de Johns Hopkins para o conselho

Galectin Therapeutics appoints Johns Hopkins neurosurgeon to board

Galectin Therapeutics Inc. (GALT) Discusses Updated Results for Belapectin in Treatment of MASH Cirrhosis and Portal Hypertension Transcript

Diretor da Galectin Therapeutics, Marc Rubin, renuncia ao conselho

Galectin Therapeutics director Marc Rubin resigns from board

CFO da Galectin Therapeutics vende ações no valor de US$ 233 mil

Galectin Therapeutics CFO sells $233k in shares

Galectin Therapeutics: Runway With Convertible Financing But Dilution Overhang Remains

oracle, micron tech among market cap stock movers on friday

Ações da Galectin Therapeutics despencam após feedback da FDA sobre medicamento

Galectin Therapeutics stock plummets after FDA feedback on drug

FDA provides feedback on Galectin’s belapectin development program